Teneligliptin Hydrobromide Dhexdhexaad CAS 401564-36-1 Nadiifinta>99.5% (HPLC) Warshada
Bixinta Teneligliptin Hydrobromide Dhexdhexaadiyeyaasha La Xiriira ee Nadiifinta Sare leh
Teneligliptin Hydrobromide CAS 906093-29-6
1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazine CAS 401566-79-8
Teneligliptin Hydrobromide Dhexdhexaadiyaha CAS 401564-36-1
| Magaca Kiimikada | (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester |
| La mid ah | (S)-tert-Butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate;3-((S)-1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl) -1,3-thiazolidine;(2S)-4-oxo-2-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidine-1-carboxylate;Teneligptin Dhexdhexaadiyaha B |
| Lambarka CAS | 401564-36-1 |
| Lambarka CAT | RF-1818 |
| Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
| Qaanuunka molecular | C13H20N2O4S |
| Miisaanka Molecular | 300.37 |
| Cufnaanta | 1.305 |
| Summada | Kiimikada Ruifu |
| Shayga | Heerka Kormeerka | Natiijooyinka |
| Muuqashada | Cadaan ilaa Midab Labeen Adag | U hoggaansamo |
| Aqoonsiga | IR;HPLC RT | U hoggaansamo |
| Khasaare xagga qalajinta | <1.00% | 0.20% |
| Walxaha laxidhiidha | Mid kasta oo wasakh ah <0.50% | 0.24% |
| Wadarta wasakhnimada <0.50% | 0.39% | |
| Qiimayn | 99.5% ~ 102.0% (oo ku salaysan qalalan) | 99.8% |
| Nadiifinta Enantiomeric | >99.5% | 99.9% |
| Sulfated Ash | <0.20% | 0.02% |
| Heerka Imtixaanka | Heerka Ganacsiga | |
| Isticmaalka | Dhexdhexaadiyaha Teneligliptin Hydrobromide (CAS: 906093-29-6) | |
Xidhmada: Dhalo, bacda bireed aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka
(2S) -4-Oxo-2-(3-thiazolidinylcarbonyl) -1-pyrrolidinecarboxylic acid tert-butyl ester (CAS: 401564-36-1) waa dhexdhexaad ah oo loo isticmaalo in lagu diyaariyo dipeptidyl peptidase IV (DPP-IV) inhibitor, dhexdhexaad ah. ee Teneligliptin Hydrobromide (CAS: 906093-29-6).Teneligliptin waa DPP-4 inhibitor kaas oo laga ansixiyey Japan 2012 daawaynta nooca II ee sonkorowga.Waxaa helay oo soo saaray Mitsubishi Tanabe Pharma oo hoos imanaya magaca ganacsiga Tenelia®.Si la mid ah kuwa kale ee DPP-4 inhibitors ah, Teneligliptin si fiican ayaa loogu dulqaaday dhammaan daraasadaha iyo qiyaasta QD waxay soo saartay tallaabo joojin dheer oo ka dhan ah DPP-4 iyo korodhka heerarka GLP-1 ee firfircoon, oo leh heerar aad u hooseeya ee qashin-saarka kelyaha.
